Articles
Have a say: What is your preferred way to receive policy relevant information?
In this short questionnaire we aim to identify the most suitable ways to transfer policy relevant information – the questionnaire is open until 20th March 2026.
Partner Spotlight
MACRAMÉ Partner Spotlight: Epithelix
Epithelix (www.epithelix.com) is a pioneering biotechnology company specialized in tissue engineering and in vitro respiratory disease modelling.
Press
Building Trust in the Integration of Artificial Intelligence into Chemical Risk Assessment
MACRAMÉ Project Partners AcumenIST have published an article about the discussions and conclusions of a workshop that elucidated how Artificial Intelligence (AI) is increasingly influencing chemical risk assessment, enabling faster, more comprehensive, and potentially more ethical assessments.
Articles
Call for evidence for the Advanced Materials Act – MACRAMÉ provided a response
With the expertise brought together in MACRAMÉ and the experiences gained throughout the project duration, MACRAMÉ responded to the call for evidence to the Advanced Materials Act.
Events
Join us at the HaDEA Showcase Event
On Monday, 19. January 2026, the European Health and Digital Executive Agency (HaDEA) will be holding the second edition of the HaDEA Showcase Event, we will highlight EU-funded projects and synergies from across HaDEA’s portfolio, in the context of key EU policy initiatives; the Competitiveness Compass and the EU Preparedness Union Strategy. The full agenda is available here. Dr Read more
Events
MACRAMÉ Presentations in 2025
In 2025, MACRAMÉ Partners presented key results in posters and talks and attended panel discussions at various events.
Articles
New Publication: Boron Nitride Nanomaterials Trigger Immunomodulatory Effects in Human Broncho-Epithelial Cells by Modulating Eicosanoid Lipid Signaling
MACRAMÉ colleagues from EMPA contributed to the publication ‘Boron Nitride Nanomaterials Trigger Immunomodulatory Effects in Human Broncho-Epithelial Cells by Modulating Eicosanoid Lipid Signaling’. For the successful commercial development of emerging 2D materials, it is crucial to understand their potential biological effects on healthy and diseased individuals.
Events
MACRAMÉ key outcomes presented at the SSbD Conference 2025
MACRAMÉ Partners presented key outcomes and used the great opportunity to discuss with many experts at the SSbD Conference 2025, 10th – 12th November, 2025 in Zurich (Switzerland)
Events
3rd Harmonisation & Standardisation Workshop on Test Methods for Nanomaterials and Advanced Materials – Presentations available
The Horizon Europe projects MACRAMÉ, iCARE, nanoPASS and DESIDERATA jointly organised an exclusive two-day virtual workshop advancing the harmonization and standardization of testing methodologies for nanomaterials and advanced materials.
Partner Spotlight
MACRAMÉ Partner Spotlight: MyBiotech GmBH
MyBiotech GmbH is a dynamic CDMO headquartered in Germany offering end-to-end development, manufacturing services, and cutting‑edge products for the biotechnology and pharmaceutical sectors. …
